In Brief: Guidant
This article was originally published in The Gray Sheet
Executive Summary
Guidant: Commences U.S. roll-out of its Ventak AV II DR automatic implantable cardioverter defibrillator. Approved by FDA via premarket approval application supplement in December and designed for pectoral implantation, the device features dual-chamber adaptive-rate pacing, which automatically adjusts the level of pacing support depending on patient activity. The device, which debuted in Europe in September 1997 ("The Gray Sheet" Sept. 22, In Brief), offers Guidant's Atrial View technology for discriminating between life-threatening ventricular rhythms and non-life-threatening supraventricular arrhythmias...